William Roper - DaVita HealthCare Independent Director

DVA Stock  USD 136.85  1.60  1.18%   

Director

Dr. William L. Roper, M.D., MPH, serves as Independent Director of the DaVita HealthCare Partners Inc. Dr. Roper was one of our directors since May 2001. In January 2019, Dr. Roper became interim president of the University of North Carolina System, North Carolina system of public higher education. Prior to that, Dr. Roper was chief executive officer of the University of North Carolina Health Care System, dean of the UNC School of Medicine and vice chancellor for medical affairs of UNC since March 2004. Dr. Roper has also served on the board of directors of Cigna Corporationrationration, a health services corporation, since December 2018. Dr. Roper also continues to serve as a professor of health policy and administration in the UNC School of Public Health and a professor of pediatrics and of social medicine in the UNC School of Medicine. From 1997 until March 2004, he was dean of the UNC School of Public Health. Before joining UNC in 1997, Dr. Roper served as senior vice president of Prudential Health Care. He also served as director of the Centers for Disease Control and Prevention from 1990 to 1993, on the senior White House staff in 1989 and 1990 and as the administrator of Centers for Medicare Medicaid Services from 1986 to 1989. Dr. Roper was a member of and is the immediate past chairman of the board of the National Quality Forum, a nonprofit organization that aims to improve the quality of healthcare. From December 2007 to November 2011, Dr. Roper served on the board of Medco Health Solutions, Inc., a pharmacy benefits management company, and from November 2011 until December 2018 served on the board of its successor company, Express Scripts Holding Company since 2001.
Age 69
Tenure 23 years
Phone720 631 2100
Webhttps://www.davita.com
Roper brings substantial expertise in the medical field, an indepth understanding of the regulatory aspects of our business as well as clinical, financial and operational experience.

DaVita HealthCare Management Efficiency

The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3853 %, implying that it generated $0.3853 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 11.12 B in debt with debt to equity (D/E) ratio of 5.68, demonstrating that the company may be unable to create cash to meet all of its financial commitments. DaVita HealthCare has a current ratio of 1.38, which is typical for the industry and considered as normal. Debt can assist DaVita HealthCare until it has trouble settling it off, either with new capital or with free cash flow. So, DaVita HealthCare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DaVita HealthCare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DaVita to invest in growth at high rates of return. When we think about DaVita HealthCare's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Erez HaimovitzMedigus Ltd ADR
N/A
Wesley SchackEdwards Lifesciences Corp
74
Moshe ShohamMicrobot Medical
64
Kieran GallahueEdwards Lifesciences Corp
57
Yoav WaizerMicrobot Medical
51
Steven LorangerEdwards Lifesciences Corp
69
Yair RabinowitchMedigus Ltd ADR
71
Yuval YanaiMedigus Ltd ADR
65
Martha MarshEdwards Lifesciences Corp
72
William LinkEdwards Lifesciences Corp
Yair RabinovitchMedigus Ltd ADR
67
Doron BirgerMedigus Ltd ADR
66
Efrat VenkertMedigus Ltd ADR
46
Paul LaVioletteEdwards Lifesciences Corp
63
Solomon MayerMicrobot Medical
62
Aviel ShapiraMedigus Ltd ADR
61
Leslie HeiszEdwards Lifesciences Corp
60
Yoseph BornsteinMicrobot Medical
65
Jeremy StarkweatherMedigus Ltd ADR
42
Barbara McNeilEdwards Lifesciences Corp
74
Anat NaschitzMedigus Ltd ADR
N/A
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Davita Healthcare operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 69000 people. DaVita HealthCare Partners (DVA) is traded on New York Stock Exchange in USA. It is located in 2000 16th Street, Denver, CO, United States, 80202 and employs 70,000 people. DaVita HealthCare is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

DaVita HealthCare Leadership Team

Elected by the shareholders, the DaVita HealthCare's board of directors comprises two types of representatives: DaVita HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DaVita. The board's role is to monitor DaVita HealthCare's management team and ensure that shareholders' interests are well served. DaVita HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DaVita HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Hearty, Chief Compliance Officer
Shawn Guertin, Director
Javier Rodriguez, Chief Executive Officer, Director
Paula Price, Independent Director
James Hilger, Interim CFO and Chief Accounting Officer
Paul Diaz, Independent Director
Misha Palecek, Chief Business
Christopher Berry, Group Officer
Jeffrey Giullian, Chief Care
Robert Lang, President International Business
John Nehra, Independent Director
Peter Grauer, Lead Independent Director
Phyllis Yale, Independent Director
Craig Samitt, Executive Vice President; CEO of HealthCare Partners
Robert Margolis, Co-Chairman of the Board
Joseph Mello, COO of HealthCare Partners
Jim Gustafson, Vice President - Investor Relations
John Winstel, Chief Accounting Officer, Group Vice President
Roger Valine, Independent Director
Kenneth Smith, Chief Officer
Gregory Moore, Independent Director
David Roer, Chief Medical Officer - DaVita Integrated Kidney Care
FRCPC MD, Chief Operations
Atul Mathur, Executive Vice President of Global Operations
Joel Ackerman, Chief Financial Officer, Treasurer
Kathleen Waters, Chief Legal and Public Affairs Officer
Pamela Arway, Independent Chairman of the Board
Michael Staffieri, Chief Operating Officer- DaVita Kidney Care
Pascal Desroches, Independent Director
LeAnne Zumwalt, Group Vice President - purchasing and government affairs
Kenny Gardner, Chief People Officer - DaVita Kidney Care
Kim Rivera, Chief Legal Officer
Carol Davidson, Independent Director
Barbara Desoer, Independent Director
Dennis Kogod, CEO of International and President of Healthcare Partners
William Roper, Independent Director
Mihran Naljayan, Chief Medical Officer - Home Modalities
Charles Berg, Independent Director
Jeanine Jiganti, Chief Compliance Officer
Laura Mildenberger, Chief People Officer - Kidney Care
MSc MD, Chief International
Kent Thiry, Chairman, CEO and CEO of Healthcare Partners

DaVita Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DaVita HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with DaVita HealthCare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DaVita HealthCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DaVita HealthCare will appreciate offsetting losses from the drop in the long position's value.

Moving together with DaVita Stock

  0.79RNLX Renalytix AI Report 4th of April 2024 PairCorr

Moving against DaVita Stock

  0.91KA Kineta Inc Report 29th of March 2024 PairCorr
  0.86TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.83MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.71MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.62MASS 908 Devices Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to DaVita HealthCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DaVita HealthCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DaVita HealthCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DaVita HealthCare Partners to buy it.
The correlation of DaVita HealthCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DaVita HealthCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DaVita HealthCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DaVita HealthCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for DaVita Stock analysis

When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.